4-butyrolactone has been researched along with B-Cell Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Tang, YM; Wang, ZJ; Xu, XJ; Zhao, HZ | 1 |
1 other study(ies) available for 4-butyrolactone and B-Cell Leukemia
| Article | Year |
|---|---|
ZCH-2B8a, an antibody targeting actin-binding protein coronin-1a, is a potential therapeutic agent for B-lineage malignancies.
Topics: 4-Butyrolactone; Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Cricetulus; Electrophoresis, Polyacrylamide Gel; Hybridomas; Leukemia, B-Cell; Mice; Microfilament Proteins; Microscopy, Fluorescence | 2014 |